“Musculoskeletal diseases cause significant disability and, particularly as populations age, it is important that we develop new treatments to keep people mobile and free from pain. The CASMI initiative is an important part of the process of discovering novel therapies.”
Professor Andrew Carr
Andy Carr is the Nuffield Professor of Orthopaedic Surgery at the University of Oxford. He founded and directs the Botnar Research Institute and is director of the NIHR, Oxford, Musculoskeletal Biomedical Research Unit. His research interests are primarily focused on developing and evaluating surgical technologies including joint replacement, arthroscopy and tissue engineering. His group investigates cellular and molecular mechanisms of tendon, muscle and cartilage pathology and is developing novel regenerative medicine scaffolds for tissue repair. His methodological research includes the development of a series of patient reported outcome measures for orthopeadic surgery. The Oxford Scores are now used worldwide in multi-centre trials and national joint replacement registers. He is chief investigator on national multi-centre randomized trials of shoulder surgery (UKUFF and CSAW trials), early phase experimental trials of growth factors (PaROT trial) and novel tissue engineering scaffolds.
He is President of the British Elbow and Shoulder Society (BESS) and Editor-in-Chief of Bone & Joint Research (BJR). He was elected a fellow of the Academy of Medical Sciences in 2009 and is an NIHR Senior Investigator.
He is a Professorial Fellow of Worcester College, Oxford, and has a long-standing interest in the relationship of art and literature to medicine. He is a consultant to the Oxford English Dictionary and a Curator of the University of Oxford, Bodleian Libraries.